Ingentium Inc.

Ingentium proposes a technically relevant solution using LLMs and semantic graphs for medical research. However, the submission is significantly penalized for highly exaggerated, unsupported claims ('most people have used my product') and sparse data regarding actual traction, revenue, or active users despite a 2015 launch. While market timing is excellent, the lack of verifiable metrics keeps the score modest.